Benin is not a big forest country, and the sustainable management of forest relics and their resources is a priority for the managers. This study was conducted in the forest regions of Pobè and Kétou ...located in Southeast Benin with the objective of characterizing the ethnobotanical forest species prioritized by the local populations for their different uses. Specifically, it aimed to identify the ethnobotanical priority species for conservation, characterize the ethnobotanical value of these priority species, and analyze the tree organ harvesting methods used for the sustainable management of the forest species. Data have been collected from 287 local populations investigated and on the specimens collected on the field, which allowed to identify the scientific name. The combination of the citation frequencies, the method of reproduction, the vulnerability scores, and the IUCN status of the species has allowed to identify five priority ethnobotanical species per forest. The software Ri386_3.5.1 has been used for the different analysis such as the calculation of the various frequencies and the correspondence factor analysis to show the relationships between socioethnic groups, organs used, and the categories of use. The priority species identified in the forest of Pobè are Milicia excelsa, Khaya senegalensis, Anogeissus leiocarpa, Ceiba pentandra, and Adansonia digitata. The priority species identified in the forest of Dogo-Kétou are Vitellaria paradoxa, Prosopis africana, Pterocarpus erinaceus, Khaya senegalensis, and Anogeissus leiocarpa. This study has revealed 54 tree species gathered into 47 genera and 25 botanical families. Their different parts have been harvested for many kinds of utilization such as medicinal, commercial, feeding, medico-magic, and artisanal. The most commonly used organs were leaves, fruits, seeds, barks, roots, and wood. The harvesting methods include cutting poles, cutting twigs and branches to harvest leaves, debarking the trunk, felling trees for wood, cutting roots, picking and harvesting fruits and seeds, and harvesting of flowers. Cutting down trees and picking flowers, fruits, and seeds have been the methods of harvesting, which affect negatively regeneration of the tree populations. It is then important to sensitize the local people on the sustainable management of their forest resources through the conception and implementation of a project program focused on forest conservation.
Here two chemical reduction pathways to synthesize the vinylene carbonate (VC) and poly(VC) reduction products are investigated, with the precise aim of further deciphering the lithium-ion battery ...solid electrolyte interphase (SEI) layer composition and the associated reduction mechanisms. The liquid synthesis pathway offers the opportunity of varying the concentration of Li-4,4′-Di-tert-butylbiphenyl reducing agent, whereas the dry synthesis pathway by ball milling allows to solve issues related to solvent-induced side reactions and washing procedure. As a result, the two syntheses do not unveil the same reduction mechanisms, favouring either carboxylate or carbonate salts as the major end product. The latter pathway is very efficient in terms of providing SEI-layers products resulting in well-defined IR spectra and comparisons with simulated spectra enable us to obtain IR fingerprints of the Li di-vinylene di-carbonate (LDVD) compound. Taken together the synthesis procedures provide information on conditions favouring radical polymerization and further poly(VC) reduction into Li2CO3 and polyacetylene. Overall, this chemical simulation of SEI-layers formation assists in a proper characterization of the SEI-layers created on graphite surfaces by their IR spectra showing that Li2CO3, LDVD and poly(VC) are all present in different proportions dependent on the VC content in the electrolyte.
•Li2CO3, Li divinylene dicarbonate and poly(VC) are all VC-derived SEI-layer compounds.•Poly(VC) can be reduced into Li2CO3 and polyacetylene.•Dry ball milling with Li is helpful to synthesize SEI reduction compounds.•Radical polymerization processes prevail in presence of small amount of VC radicals.•EC also participates to the SEI formation in presence of electrolyte with 2 wt% VC.
The nutritional status of elite soccer players across match, postmatch, training and rest days has not been defined. Recent evidence suggests the pattern of dietary protein intake impacts the daytime ...turnover of muscle proteins and, as such, influences muscle recovery. We assessed the nutritional status and daytime pattern of protein intake in senior professional and elite youth soccer players and compared findings against published recommendations. Fourteen senior professional (SP) and 15 youth elite (YP) soccer players from the Dutch premier division completed nutritional assessments using a 24-hr web-based recall method. Recall days consisted of a match, postmatch, rest, and training day. Daily energy intake over the 4-day period was similar between SP (2988 ± 583 kcal/day) and YP (2938 ± 465 kcal/day; p = .800). Carbohydrate intake over the combined 4-day period was lower in SP (4.7 ± 0.7 g·kg-1 BM·day-1) vs. YP (6.0 ± 1.5 g·kg-1 BM·day-1, p = .006) and SP failed to meet recommended carbohydrate intakes on match and training days. Conversely, recommended protein intakes were met for SP (1.9 ± 0.3 g·kg-1 BM·day-1) and YP (1.7 ± 0.4 g·kg-1 BM·day-1), with no differences between groups (p = .286). Accordingly, both groups met or exceeded recommended daily protein intakes on individual match, postmatch, rest and training days. A similar "balanced" daytime pattern of protein intake was observed in SP and YP. To conclude, SP increased protein intake on match and training days to a greater extent than YP, however at the expense of carbohydrate intake. The daytime distribution of protein intake for YP and SP aligned with current recommendations of a balanced protein meal pattern.
The Antarctic Zone, the southernmost belt of the Antarctic Circumpolar Current, plays an important role in the control of atmospheric carbon dioxide concentrations. In the last decade, a number of ...studies have highlighted the importance of diatom assemblage composition in influencing the magnitude of the organic carbon and biogenic silica fluxes exported out of the mixed layer in Southern Ocean ecosystems. Here we investigate the relationship between the makeup of the diatom assemblage, organic carbon and biogenic silica export and several significant environmental parameters using sediment trap records deployed in different sectors of the Antarctic Zone. The study is divided in two parts. We first present unpublished diatom species flux data collected by a sediment trap in the offshore waters of Prydz Bay (Station PZB-1) over a year. The results of this study revealed a major export peak of diatom valves in Austral summer and two small unexpected secondary flux pulses during full winter conditions. The summer diatom sinking assemblages were largely composed of small and rapidly dividing species such as Fragilariopsis cylindrus, Fragilariopsis curta and Pseudo-nitzschia lineola, while winter assemblages were dominated by Fragilariopsis kerguelensis most reflecting its persistent strategy and selective preservation.
In the second part of the study, we compare the annual diatom assemblage composition and biogeochemical fluxes of Station PZB-1 with flux data documented in previous sediment trap studies conducted in other sectors of the Antarctic Zone in order to investigate how diatom floristics influence the composition and magnitude of particle fluxes in the Antarctic Zone. The lack of correlation between the annual diatom valve, organic carbon and biogenic silica fluxes across stations indicates that other factors aside from diatom abundance play a major role in the carbon and silica export in AZ. Among these factors, the composition of the diatom assemblage appears to be critical, as suggested by the strong and significant correlation between Bio-SiO2 and the valve fluxes of F. kerguelensis alone, that this species is the main Bio-SiO2 vector from the surface layer to the deep ocean in the AZ waters, regardless of its relative abundance. Lastly, the good correlation between the annual fluxes of the group of small Fragilariopsis species with satellite-derived chlorophyll-a concentration estimates over the study stations, suggest that high abundances of these species in the Southern Ocean paleorecords could be used as a proxy of high algal biomass accumulation.
BACKGROUNDAccumulation of advanced glycation endproducts (AGEs) may contribute to the pathophysiology of type 2 diabetes and its vascular complications. AGEs are widely present in food, but whether ...restricting AGE intake improves risk factors for type 2 diabetes and vascular dysfunction is controversial.METHODSAbdominally obese but otherwise healthy individuals were randomly assigned to a specifically designed 4-week diet low or high in AGEs in a double-blind, parallel design. Insulin sensitivity, secretion, and clearance were assessed by a combined hyperinsulinemic-euglycemic and hyperglycemic clamp. Micro- and macrovascular function, inflammation, and lipid profiles were assessed by state-of-the-art in vivo measurements and biomarkers. Specific urinary and plasma AGEs Nε-(carboxymethyl)lysine (CML), Nε-(1-carboxyethyl)lysine (CEL), and Nδ-(5-hydro-5-methyl-4-imidazolon-2-yl)-ornithine (MG-H1) were assessed by mass spectrometry.RESULTSIn 73 individuals (22 males, mean ± SD age and BMI 52 ± 14 years, 30.6 ± 4.0 kg/m2), intake of CML, CEL, and MG-H1 differed 2.7-, 5.3-, and 3.7-fold between the low- and high-AGE diets, leading to corresponding changes of these AGEs in urine and plasma. Despite this, there was no difference in insulin sensitivity, secretion, or clearance; micro- and macrovascular function; overall inflammation; or lipid profile between the low and high dietary AGE groups (for all treatment effects, P > 0.05).CONCLUSIONThis comprehensive RCT demonstrates very limited biological consequences of a 4-week diet low or high in AGEs in abdominally obese individuals.TRIAL REGISTRATIONClinicaltrials.gov, NCT03866343; trialregister.nl, NTR7594.FUNDINGDiabetesfonds and ZonMw.
Objective
To identify predictors of acute treatment response for nonprescription (over‐the‐counter OTC) medications among people with migraine and develop improved models for predicting treatment ...response.
Background
Pain freedom and sustained pain relief are important priorities in the acute treatment of migraine. OTC medications are widely used for migraine; however, it is not clear which treatment works best for each patient without going through the trial and error process.
Methods
A prediction model development study was completed using the 2006 American Migraine Prevalence and Prevention Study survey, from participants who were aged ≥18, met criteria and headache day frequency for episodic migraine, did not take prescription medication for migraine, and used ≥1 of the following acute migraine medication classes: acetaminophen, aspirin, NSAIDs, or caffeine containing combination products (CCP). Two items from the Migraine Treatment Optimization Questionnaire were used to evaluate treatment response, adequate 2‐h pain freedom (2hPF) and 24‐h pain relief (24hPR), which were defined by a response to treatment ≥half the time at 2 h and 24 h post treatment, respectively. We identified predictors of adequate treatment response and developed models to predict probability of treatment response to each medication class.
Results
The sample included 3852 participants (3038 79.0% females) with an average age of 45.0 years (SD = 12.8). Only 1602/3852 (41.6%) and 1718/3852 (44.6%) of the participants reported adequate 2hPF and 24hPR, respectively. Adequate treatment‐response was significantly predicted by lower average headache pain intensity, less cutaneous allodynia, and lower depressive symptom scores. Lower migraine symptom severity was predictive of adequate 2hPF and fewer monthly headache days was predictive of adequate 24hPR. Among participants reporting OTC monotherapy (n = 2168, 56.3%) individuals taking CCP were more likely to have adequate 2hPF (OR = 1.55, 95% CI 1.23–1.95) and 24hPR (OR = 1.79, 95% CI 1.18–1.88) in comparison with those taking acetaminophen. Predictive models were modestly predictive of responders to OTC medications (c‐statistics = 0.65; 95% CI 0.62–0.68).
Conclusion
These results show that response to acute migraine treatments is not optimized in the majority of people with migraine treating with OTC medications. Predictive models can improve our ability to choose the best therapeutic option for individuals with episodic migraine and increase the proportion of patients with optimized response to treatments.
Both continuous therapy with acalabrutinib and fixed-duration therapy with venetoclax–obinutuzumab are effective for previously untreated chronic lymphocytic leukaemia. We hypothesised that frontline ...time-limited, minimal residual disease (MRD)-guided triplet therapy with acalabrutinib, venetoclax, and obinutuzumab would induce deep (ie, more patients with undetectable MRD) and durable remissions.
In this open-label, single-arm, investigator-sponsored, phase 2 study, patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma were recruited from two academic hospitals in Boston, MA, USA. Eligible patients were aged 18 years or older, with an Eastern Cooperative Oncology Group performance status of 0–2, and were treatment naive. Patients were treated in 28 day cycles. Acalabrutinib monotherapy was given orally at 100 mg twice daily for cycle 1, then combined for six cycles with intravenous obinutuzumab (100 mg on cycle 2 day 1, 900 mg on day 2, 1000 mg on day 8, and 1000 mg on day 15 and on day 1 of cycles 3–7); and from the beginning of cycle 4, oral venetoclax was dosed daily using an accelerated ramp-up from 20 mg on day 1 to 400 mg by day 22 and continued at this dose thereafter. Patients continued on acalabrutinib 100 mg twice daily and venetoclax 400 mg once daily until day 1 of cycle 16 or day 1 of cycle 25. If the patient had undetectable MRD in the bone marrow they were given the option to discontinue therapy at the start of cycle 16 (if also in complete remission) or at the start of cycle 25 (if at least in partial remission). The primary endpoint was complete remission with undetectable MRD in the bone marrow (defined as <1 chronic lymphocytic leukaemia cell per 10 000 leucocytes as measured by four-colour flow cytometry), at cycle 16 day 1. Safety and activity endpoints were assessed in all patients who received at least one dose of any study drug. This study is registered with ClinicalTrials.gov, NCT03580928, and is ongoing.
Between Aug 2, 2018, and May 23, 2019, 37 patients with chronic lymphocytic leukaemia were enrolled and all received at least one dose of any study drug. The median age of patients was 63 years (IQR 57–70), and ten (27%) were female and 27 (73%) were male. Median follow-up was 27·6 months (IQR 25·1–28·2). At cycle 16 day 1, 14 (38% 95% CI 22–55) of 37 participants had a complete remission with undetectable MRD in the bone marrow. The most common grade 3 or 4 haematological adverse event was neutropenia (16 43% of 37 patients). The most common grade 3–4 non-haematological adverse events were hyperglycaemia (three 8%) and hypophosphataemia (three 8%). Serious adverse events occurred in nine (24%) patients; the most common was neutropenia in three (8%) patients. There have been no deaths on study.
Acalabrutinib, venetoclax, and obinutuzumab is a highly active and well tolerated frontline therapy for chronic lymphocytic leukaemia. Although the primary endpoint of this study was not met, the high proportion of patients who had undetectable MRD in the bone marrow supports further investigation of this regimen, which is being tested against acalabrutinib–venetoclax and chemoimmunotherapy in an ongoing phase 3 study (NCT03836261).
AstraZeneca and a Dana-Farber Cancer Institute Collaborative Award.
Polymorphisms along the hepatitis B virus (HBV) genome have an impact on disease outcome, sensitivity to antiviral treatment, escape from vaccination, and laboratory diagnosis. We have designed a ...diagnostic tool based on duplex amplification of the whole HBV genome and a high-density DNA chip designed to detect 245 mutations, 20 deletions, and 2 insertions at 151 positions and to determine the genotype of the virus in serum. Assay performances were evaluated with 170 samples, characterized by determination of viral load and sequencing of the Pol, S, and precore genes and the basal core promoter. One hundred fifty-three samples (90%) could be amplified and analyzed by the chip. Only two samples with more than 10³ genome copies/ml could not be analyzed. Genotype had no impact on analytical sensitivity. Reproducibility studies showed no difference between repeats for codon and genotype determination. Genotype determination by sequencing and the chip were concordant in 148 of 151 samples. Twelve thousand one hundred sixty-one codons were analyzed by both techniques. Only 89.4% could be determined by sequencing, and among the remaining 11,335 codons, 92.8% were identical by sequencing and the chip. Failures to identify an amino acid by the chip were mainly due to reduced hybridization efficiency attributed to unexpected polymorphisms. Optimization of the chip-based reagent for the analysis of the HBV genome is ongoing. This first evaluation showed that DNA chip technology can provide important information in relation to the clinical management of chronic hepatitis B.
Rapid scale-up of antiretroviral therapy (ART) in resource-limited settings is accompanied with an increasing risk of HIV drug resistance (HIVDR), which in turn could compromise the performance of ...national ART rollout programme. In order to sustain the effectiveness of ART in a resource-limited country like Cameroon, HIVDR early warning indicators (EWI) may provide relevant corrective measures to support the control and therapeutic management of AIDS.
A retrospective study was conducted in 2010 among 40 ART sites (12 Approved Treatment Centers and 28 Management Units) distributed over the 10 regions of Cameroon. Five standardized EWIs were selected for the evaluation using data from January through December, among which: (1) Good ARV prescribing practices: target = 100%; (2) Patient lost to follow-up: target ≤ 20%; (3) Patient retention on first line ART: target ≥ 70%; (4) On-time drug pick-up: target ≥ 90%; (5) ARV drug supply continuity: target = 100%. Analysis was performed using a Data Quality Assessment tool, following WHO protocol.
THE NUMBER OF SITES ATTAINING THE REQUIRED PERFORMANCE ARE: 90% (36/40) for EWI(1), 20% (8/40) for EWI(2); 20% (8/40) for EWI(3); 0% (0/37) for EWI(4); and 45% (17/38) for EWI 5. ARV prescribing practices were in conformity with the national guidelines in almost all the sites, whereas patient adherence to ART (EWI(2), EWI(3), and EWI(4)) was very low. A high rate of patients was lost-to-follow-up and others failing first line ART before 12 months of initiation. Discontinuity in drug supply observed in about half of the sites may negatively impact ARV prescription and patient adherence. These poor ART performances may also be due to low number of trained staff and community disengagement.
The poor performance of the national ART programme, due to patient non-adherence and drug stock outs, requires corrective measures to limit risks of HIVDR emergence in Cameroon.
Celotno besedilo
Dostopno za:
DOBA, IZUM, KILJ, NUK, PILJ, PNG, SAZU, SIK, UILJ, UKNU, UL, UM, UPUK
PDF
